Loreto Martínez‐González

Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors

Annachiara Gandini, Manuela Bartolini, Daniele Tedesco et al. · Journal of Medicinal Chemistry · 2018 · 102 citations · Full text

Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment

Loreto Martínez‐González, Carmen Rodríguez‐Cueto, Diego Cabezudo et al. · Scientific Reports · 2020 · 63 citations · Full text

Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis

Loreto Martínez‐González, Claudia Gonzalo‐Consuegra, Marta Gómez‐Almería et al. · International Journal of Molecular Sciences · 2021 · 55 citations · Full text

Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson’s Disease

Rita Maria Concetta Di Martino, Letizia Pruccoli, Alessandra Bisi et al. · ACS Chemical Neuroscience · 2020 · 48 citations · Full text

Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis

Elisa Rojas‐Prats, Loreto Martínez‐González, Claudia Gonzalo‐Consuegra et al. · European Journal of Medicinal Chemistry · 2020 · 46 citations · Full text

Amyotrophic Lateral Sclerosis, Nuclear Protein Tdp-43, Cell Death +6